Argent Trust’s Bristol-Myers Squibb BMY Stock Holding History

Argent Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$3.33M	Buy	52,669 +265	+0.5%	+$17K	0.91%	36
2017 Q4	$3.21M	Sell	52,404 -629	-1%	-$39.3K	0.86%	37
2017 Q3	$3.38M	Sell	53,033 -251	-0.5%	-$14.7K	0.93%	33
2017 Q2	$2.97M	Sell	53,284 -1,144	-2%	-$62.3K	0.83%	36
2017 Q1	$2.96M	Buy	54,428 +969	+2%	+$53.1K	0.84%	37
2016 Q4	$3.12M	Sell	53,459 -2,031	-4%	-$111K	0.91%	30
2016 Q3	$2.99M	Buy	55,490 +1,212	+2%	+$77.9K	0.91%	30
2016 Q2	$3.99M	Sell	54,278 -643	-1%	-$45.4K	1.24%	21
2016 Q1	$3.51M	Buy	54,921 +347	+0.6%	+$21.9K	1.12%	25
2015 Q4	$3.75M	Buy	+54,574	New	+$3.61M	1.23%	20

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Argent Trust's BMY Position: Q1 2018 in Review

Argent Trust increased its Bristol-Myers Squibb (BMY) stake by 0.51% in Q1 2018, buying an estimated $17K and bringing the position to 52,669 shares worth $3.33M. The position accounts for 0.91% of the portfolio, ranked #36.

Argent Trust first reported a position in BMY in Q4 2015 and has held it in 10 quarters since. The position peaked at $3.99M in Q2 2016. 1,746 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

Argent Trust held 52,669 shares of Bristol-Myers Squibb worth $3.33M as of Q1 2018.
Argent Trust bought 265 Bristol-Myers Squibb shares in Q1 2018, an estimated $17K.
Bristol-Myers Squibb made up 0.91% of Argent Trust's portfolio in Q1 2018, its #36 holding.
Argent Trust first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 10 quarters since.
Argent Trust's Bristol-Myers Squibb position peaked at $3.99M in Q2 2016.
1,746 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.